trending Market Intelligence /marketintelligence/en/news-insights/trending/2r7mLIaAniyk-j9WjpPFnw2 content esgSubNav
In This List

Boston Scientific to buy back $1B in outstanding debt

Video

According to Market Intelligence, December 2022

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022


Boston Scientific to buy back $1B in outstanding debt

Boston Scientific Corp. plans to buy back about $1 billion outstanding debt securities via a cash tender offer.

The tender offer is for up to $1 billion in various outstanding securities including 4.125% senior notes due 2023, 4.000% senior notes due 2028, 3.850% senior notes due 2025 and 3.375% senior notes due 2022.

The tender offers are expected to expire at midnight ET on Nov. 19.

Barclays Capital Inc., BofA Securities and Goldman Sachs & Co. LLC are acting as the lead dealer managers for the transaction.